AIMV
AI Maverick Intel, Inc., an AI company, focuses on acquiring and enhancing businesses through its proprietary AI Maverick platform. Its technology streamlines the customer acquisition process by automating two way communication and data-driven engagement with its clients ideal audience segments across healthcare, biotech, and other sectors. The company was formerly known as Bionoid Pharma Inc. and changed its name to AI Maverick Intel, Inc. in April 2025. AI Maverick Intel, Inc. was incorporated in 2006 and is based in Beverly Hills, California.
| Period | EPS | Revenue | FCF |
|---|---|---|---|
| 2025 Q2 | -0.00 | $0 | — |
| 2025 Q1 | -0.00 | $0 | — |
| 2024 Q4 | -0.00 | -$20,941 | — |
| 2024 Q3 | -0.00 | $10,983 | — |
| 2024 Q2 | -0.00 | $5,142 | $613 |
| 2024 Q1 | 0.00 | $4,816 | -$532 |
| 2023 Q4 | -0.00 | $5,525 | -$3,223 |
| 2023 Q3 | 0.00 | $3,843 | $2,687 |